Cytokines are small signaling proteins that mediate and regulate immunity, inflammation, and hematopoiesis. They act as molecular messengers between cells, coordinating the immune response to infection, tissue damage, and disease. Chemokines are a specialized subfamily of cytokines that direct cell migration (chemotaxis), guiding immune cells to sites of infection or inflammation.
Understanding cytokine biology is central to research in immunology, oncology, autoimmune disease, infectious disease, and drug development. This guide provides an overview of the major cytokine families and the research reagents used to study them.
In This Guide
1. Major Cytokine Families
2. Key Cytokine Functions
3. Research Tools for Cytokine Studies
4. Frequently Asked Questions
1. Major Cytokine Families
| Family |
Key Members |
Primary Functions |
| Interleukins (ILs) |
IL-1, IL-2, IL-4, IL-6, IL-10, IL-12, IL-17, IL-23 |
T/B cell activation, differentiation, pro- and anti-inflammatory regulation, Th1/Th2/Th17 polarization |
| TNF Superfamily |
TNF-α, TRAIL, FasL, CD40L, RANKL, BAFF |
Apoptosis, inflammation, immune cell costimulation, bone remodeling |
| Interferons (IFNs) |
IFN-α, IFN-β (Type I); IFN-γ (Type II); IFN-λ (Type III) |
Antiviral defense, MHC upregulation, macrophage activation, anti-tumor immunity |
| Chemokines |
CCL2/MCP-1, CCL5/RANTES, CXCL8/IL-8, CXCL10/IP-10, CXCL12/SDF-1 |
Leukocyte trafficking, homing, angiogenesis, tumor microenvironment modulation |
| Growth Factors |
EGF, VEGF, FGF, PDGF, TGF-β, GM-CSF, M-CSF |
Cell proliferation, differentiation, angiogenesis, wound healing, hematopoiesis |
| Colony-Stimulating Factors (CSFs) |
G-CSF, GM-CSF, M-CSF |
Hematopoietic progenitor expansion, monocyte/macrophage/granulocyte differentiation |
2. Key Cytokine Functions in Research Context
Immune activation and suppression. Pro-inflammatory cytokines (IL-1β, TNF-α, IL-6, IL-17) drive immune responses, while anti-inflammatory cytokines (IL-10, TGF-β) suppress them. The balance between these determines disease outcome in autoimmunity, infection, and cancer.
T cell polarization. Cytokines determine the differentiation fate of naive CD4+ T cells: IL-12 drives Th1 (cell-mediated immunity), IL-4 drives Th2 (humoral immunity), TGF-β + IL-6 drives Th17 (mucosal defense, autoimmunity), and TGF-β alone drives Treg (immune suppression).
Tumor microenvironment. Tumors secrete cytokines and chemokines that recruit immunosuppressive cells (Tregs, MDSCs, TAMs) and exclude effector T cells. Understanding and disrupting this signaling network is central to immuno-oncology drug development. For a deep dive into TME cell populations and markers, see our Tumor Microenvironment Research guide. Cytokine-driven immune evasion intersects closely with immune checkpoint signaling pathways.
Therapeutic targets. Many approved biologics target cytokines or their receptors: anti-TNF-α (adalimumab, infliximab), anti-IL-6R (tocilizumab), anti-IL-17A (secukinumab), anti-VEGF (bevacizumab), and anti-IL-23 (guselkumab). Research biosimilar versions of these drugs are widely used in preclinical studies.
3. Research Tools for Cytokine Studies
| Tool |
Application |
abinScience Coverage |
| Recombinant cytokine proteins |
Cell stimulation, differentiation assays, ELISA standard curves, receptor-binding studies. For handling and reconstitution best practices, see our Recombinant Protein Handling Guide. |
~590 recombinant cytokine/chemokine/growth factor proteins |
| Anti-cytokine antibodies |
WB, IHC, IF, flow cytometry, ELISA (matched pairs for sandwich ELISA), neutralization assays |
~1,730 antibodies targeting cytokines, chemokines, receptors, and growth factors |
| Research biosimilar antibodies |
PK/ADA assays, positive controls for bioanalytical methods, preclinical efficacy studies |
~600 research biosimilars of approved anti-cytokine therapeutics |
| ELISA kits |
Quantitative measurement of cytokine concentrations in serum, plasma, cell culture supernatants. For protocol details, see our ELISA Protocol Guide. |
PK/ADA ELISA kits for anti-cytokine therapeutics |
Protein→Antibody→Kit: For many cytokine targets, abinScience offers the complete research toolchain: a recombinant protein for use as an antigen or ELISA standard, antibodies for detection and neutralization, and matched ELISA kits for quantitative measurement — all from one manufacturer.
4. Frequently Asked Questions
Q: What is the difference between a cytokine and a chemokine?
All chemokines are cytokines, but not all cytokines are chemokines. Cytokine is the broad term for any small signaling protein involved in immune regulation. Chemokines are a specific subfamily (about 50 members in humans) that function primarily as chemoattractants — guiding immune cell migration through concentration gradients. Chemokines are classified into four subfamilies based on their cysteine motif: CC, CXC, CX3C, and XC.
Q: Which expression system should I use for recombinant cytokines?
For most in vitro applications (ELISA standards, WB positive controls), E. coli-expressed cytokines are sufficient and cost-effective. For cell-based functional assays (proliferation, differentiation, signaling) and in vivo studies, mammalian-expressed cytokines are preferred because they carry native post-translational modifications (glycosylation, disulfide bonds) that can affect biological activity. Check the product datasheet for bioactivity data (e.g., ED₅₀ values) to confirm functional performance.
Q: How do I measure cytokine levels in my samples?
The most common method is sandwich ELISA using matched capture and detection antibodies with a recombinant cytokine standard curve. For a step-by-step protocol, see our ELISA Protocol Guide. For multiplexed measurement of many cytokines simultaneously, bead-based multiplex assays (Luminex) or MSD electrochemiluminescence platforms are widely used. For intracellular cytokine detection at the single-cell level, intracellular cytokine staining (ICS) followed by flow cytometry is the standard approach.
Q: What is the difference between a neutralizing and a detection antibody for cytokines?
A detection antibody binds the cytokine and generates a measurable signal (for ELISA, WB, or IHC), but does not necessarily block the cytokine's biological function. A neutralizing antibody specifically blocks the cytokine from binding its receptor, thereby inhibiting its downstream signaling. The same target may require different antibody clones for detection versus neutralization, because each function depends on different epitope locations. For more on how neutralization assays work, see our Neutralization Assay Guide.
2,900+ Cytokine & Chemokine Reagents
Proteins, antibodies, biosimilars, and kits — covering interleukins, TNF superfamily, interferons, chemokines, and growth factors.
Search by Target →
References
1. Dinarello CA. Historical insights into cytokines. Eur J Immunol. 2007;37(Suppl 1):S34-S45. doi: 10.1002/eji.200737772
2. Zlotnik A, Yoshie O. The chemokine superfamily revisited. Immunity. 2012;36(5):705-716. doi: 10.1016/j.immuni.2012.05.008
3. Turner MD, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta. 2014;1843(11):2563-2582. doi: 10.1016/j.bbamcr.2014.05.014
This article is provided for educational purposes only. For technical support, contact order@abinscience.com.
中文
English
한국어
日本語
Español
Français
Русский
